BackgroundIn response to the growing concern surrounding childhood obesity, we are thrilled to introduce a Phase 1 FDA-regulated clinical trial aimed…
Baylor College of Medicine is conducting this OI Wellbeing Study as a part of the Brittle Bone Disease Consortium which aims to improve the lives of…
The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD).If eligible…
Join a free treatment study to address childhood anxiety/OCD!Is your child between the ages of 7 and 13? Does your child experience symptoms of…
What is the aim of this study?Looking for parents and children aged 4 years old to join! We are recruiting families who are interested in helping us…
Aficamten is a next-generation small molecule cardiac myosin inhibitor being developed as a chronic, oral treatment for participants with…
An Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-3745 in Participants with…
The Corvia Atrial Shunt is an investigational cardiac implant designed to reduce heart failure symptoms such as fatigue, breathlessness and…
A randomized, double-blind, placebo-controlled, 2-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients…
Prospective multi-center observational trial comparing the diagnostic accuracy of novel molecular tests (TMA and qPCR) to current CDC guidelines in…